These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

130 related articles for article (PubMed ID: 702283)

  • 21. Bioavailability of temazepam in soft gelatin capsules.
    Fuccella LM
    Br J Clin Pharmacol; 1979; 8(1):31S-35S. PubMed ID: 41540
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Relative bioavailability of danazol in dogs from liquid-filled hard gelatin capsules.
    Erlich L; Yu D; Pallister DA; Levinson RS; Gole DG; Wilkinson PA; Erlich RE; Reeve LE; Viegas TX
    Int J Pharm; 1999 Mar; 179(1):49-53. PubMed ID: 10053201
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Cinnarizine food-effects in beagle dogs can be avoided by administration in a Self Nano Emulsifying Drug Delivery System (SNEDDS).
    Christiansen ML; Holm R; Kristensen J; Kreilgaard M; Jacobsen J; Abrahamsson B; Müllertz A
    Eur J Pharm Sci; 2014 Jun; 57():164-72. PubMed ID: 24239996
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Studies on dissolution tests for soft gelatin capsules by the rotating dialysis cell (RDC) method. VI. Preparation and evaluation of ibuprofen soft gelatin capsule.
    Takahashi M; Yuasa H; Kanaya Y; Uchiyama M
    Chem Pharm Bull (Tokyo); 1995 Aug; 43(8):1398-401. PubMed ID: 7553987
    [TBL] [Abstract][Full Text] [Related]  

  • 25. The influence of polymorphism on the manufacturability and in vitro dissolution of sulindac-containing hard gelatin capsules.
    Guadalupe Sánchez-González E; Yépez-Mulia L; Jesús Hernández-Abad V; Jung Cook H
    Pharm Dev Technol; 2015 May; 20(3):306-13. PubMed ID: 24417644
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Effect of vehicle amphiphilicity on the dissolution and bioavailability of a poorly water-soluble drug from solid dispersions.
    Serajuddin AT; Sheen PC; Mufson D; Bernstein DF; Augustine MA
    J Pharm Sci; 1988 May; 77(5):414-7. PubMed ID: 3411464
    [TBL] [Abstract][Full Text] [Related]  

  • 27. In vivo efficacy and bioavailability of lumefantrine: Evaluating the application of Pheroid technology.
    du Plessis LH; Govender K; Denti P; Wiesner L
    Eur J Pharm Biopharm; 2015 Nov; 97(Pt A):68-77. PubMed ID: 26478276
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Absorption of vitamin K2 by dogs after oral administration of a soft gelatin capsule formulation containing a new emulsion-type vehicle.
    Amemiya T; Mizuno S; Hayashi Y; Yuasa H; Watanabe J
    J Pharm Pharmacol; 1999 Dec; 51(12):1375-80. PubMed ID: 10678491
    [TBL] [Abstract][Full Text] [Related]  

  • 29. The bioavailability of oral dosage forms of a new HIV-1 protease inhibitor, KNI-272, in beagle dogs.
    Kiriyama A; Sugahara M; Yoshikawa Y; Kiso Y; Takada K
    Biopharm Drug Dispos; 1996 Mar; 17(2):125-34. PubMed ID: 8907719
    [TBL] [Abstract][Full Text] [Related]  

  • 30. The in vitro bioavailability of various drugs formulated as hard gelatin capsules.
    Newton JM; Razzo FN
    J Pharm Pharmacol; 1977 Apr; 29(4):205-8. PubMed ID: 17668
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Bioavailability of a new oral methoxsalen formulation. A serum concentration and photosensitivity response study.
    Sullivan TJ; Walter JL; Kouba RF; Maiwald DC
    Arch Dermatol; 1986 Jul; 122(7):768-71. PubMed ID: 3729509
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Ketoprofen mesoporous silica nanoparticles SBA-15 hard gelatin capsules: preparation and in vitro/in vivo characterization.
    Abd-Elrahman AA; El Nabarawi MA; Hassan DH; Taha AA
    Drug Deliv; 2016 Nov; 23(9):3387-3398. PubMed ID: 27167529
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Influence of soft gelatin on digoxin absorption.
    O'Grady J; Johnson BF; Bye C; Sabey GA
    Br J Clin Pharmacol; 1978 May; 5(5):461-3. PubMed ID: 656286
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Design and evaluation of self-emulsifying drug delivery systems of Rhizoma corydalis decumbentis extracts.
    Ma H; Zhao Q; Wang Y; Guo T; An Y; Shi G
    Drug Dev Ind Pharm; 2012 Oct; 38(10):1200-6. PubMed ID: 22512784
    [TBL] [Abstract][Full Text] [Related]  

  • 35. A formulation strategy for gamma secretase inhibitor ELND006, a BCS class II compound: development of a nanosuspension formulation with improved oral bioavailability and reduced food effects in dogs.
    Quinn K; Gullapalli RP; Merisko-Liversidge E; Goldbach E; Wong A; Liversidge GG; Hoffman W; Sauer JM; Bullock J; Tonn G
    J Pharm Sci; 2012 Apr; 101(4):1462-74. PubMed ID: 22213574
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Development and bioavailability assessment of ramipril nanoemulsion formulation.
    Shafiq S; Shakeel F; Talegaonkar S; Ahmad FJ; Khar RK; Ali M
    Eur J Pharm Biopharm; 2007 May; 66(2):227-43. PubMed ID: 17127045
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Pre-clinical and clinical evaluation of solution and soft gelatin capsule formulations for a BCS class 3 compound with atypical physicochemical properties.
    Ramsay-Olocco K; Alexandrova L; Nellore R; Killion R; Li L; Coen P; Ho Q; Jung D; Rocha C
    J Pharm Sci; 2004 Sep; 93(9):2214-21. PubMed ID: 15295782
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Reactivity of enprostil stereoisomers in soft elastic gelatin capsules.
    Kenley RA; Fleitman JS; Partridge IW
    J Pharm Sci; 1986 Sep; 75(9):842-6. PubMed ID: 3097299
    [TBL] [Abstract][Full Text] [Related]  

  • 39. A strategy for preclinical formulation development using GastroPlus as pharmacokinetic simulation tool and a statistical screening design applied to a dog study.
    Kuentz M; Nick S; Parrott N; Röthlisberger D
    Eur J Pharm Sci; 2006 Jan; 27(1):91-9. PubMed ID: 16219449
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Imprinting on empty hard gelatin capsule shells containing titanium dioxide by application of the UV laser printing technique.
    Hosokawa A; Kato Y; Terada K
    Drug Dev Ind Pharm; 2014 Aug; 40(8):1047-53. PubMed ID: 23786207
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.